Rob Dillard

DocwireNews

Changes in the bone marrow microbiome and proteome can help distinguish between patients with myeloproliferative neoplasms (MPN) and essential thrombocythemia (ET) and those with prefibrotic primary myelofibrosis (pre-PMF), according to a study <a href="https://ash.confex.com/ash/2023/webprogram/Paper189072.html" target="_blank" rel="noopener">presented</a> at the 65th ASH Annual Meeting &amp; Exposition, which is taking place December 9-12 in San Diego, California.
&#8220;It is increasingly recognized that the bone marrow microenvironment, including inflammation and metabolic imbalances, influences disease progression. So far, there have been few studies focusing on the combined analysis of the bone marrow microbiome and proteome in MPN patients,&#8221; the researchers wrote.
In this study, Anqi Zhang and colleagues assessed changes in the bone marrow microbiome and proteome and their association with pathogenesis in patients with ET and pre-PMF. They analyzed the formalin-fixed, paraffin-embedded (FFPE) bone marrow slides from 6 patients with untreated pre-PMF (median age, 64 years) and 7 patients with ET (median age, 53 years). They then conducted proteomic analysis of the FFPE tissue slides of bone marrow from 13 patients using 4-dimensional data-independent acquisition technology. The bone marrow microenvironment was analyzed using 2bRAD-M sequencing.
The results showed that JAK2 V617F mutations were more frequent in patients with pre-PMF than in those with ET (17.9% vs 55.8%; P=.001). The researchers observed that lactate dehydrogenase in patients with pre-PMF was higher than in those with ET, and this difference was statistically significant (P=.007). Also, the researchers found that high-density lipoprotein cholesterol in the pre-PMF patients was appreciably reduced, indicating a difference in lipid metabolism between patients with pre-PMF and those with ET.
Overall, the study uncovered that bone marrow microbial diversity and richness was higher in patients with pre-PMF. &#8220;We have shown that there are multilevel differences, including the proteome and microbiome, between ET and pre-PMF patients. This could potentially provide new insights for distinguishing and treating these 2 disease subtypes,&#8221; the investigators concluded.
Reference
Zhang A, Sun T, Yang R, Zhang L. Comparative analysis of bone marrow microbiome and proteome differences between essential thrombocythaemia and prefibrotic primary myelofibrosis. Abstract #4577. Presented at the 65th ASH Annual Meeting &amp; Exposition; December 9-12, 2023; San Diego, California.

Cecilia Brown

2025 Cancer Statistics Report: Lung Cancer Remains Leading Cause of Cancer Mortality in US

Lung Cancer

Emily Menendez

Cytokine-Induced Killer Cells Boost RFS, CSS in HCC in Extended Follow-Up

Liver Cancer

DEEPER Trial Final Analysis: m-FOLFOXIRI, Cetuximab Boosts PFS, OS in mCRC

Colorectal Cancer

Latest News

Bone Marrow Microbiome, Proteome Differences Between Patients With ET, Prefibrotic PMF

Conference Coverage

Changes in the bone marrow microbiome and proteome can help distinguish between patients with ET and those with prefibrotic PMF.

About Us

Editorial Policy

Advertising

eNewsletters

Contribute

Contact Us

MashupMD

Blood Cancers Today

Cancer Nursing Today

GU Oncology Now

Urban Health Today

Bile Duct Cancer

Gastroesophageal Cancer

Gastric Cancer

GEP-NETs

GIST

Pancreatic Cancer

GI Oncology Now

Anemia

Deep Vein Thrombosis

Essential Thrombocythemia

Hemophilia

Immune Thrombocytopenic Purpura

Myelodysplastic Syndromes

Myelofibrosis

Myeloproliferative Neoplasms

Polycythemia Vera

Pulmonary Embolism

Sickle Cell Disease

Thrombocytopenia

Thrombophilia

Thrombosis

Thrombotic Thrombocytopenic Purpura

Venous Thromboembolism

von Willebrand Disease

Heme Today

Acute Kidney Injury

ADPKD

Anemia and Kidney Disease

Chronic Kidney Disease

COVID-19 and Kidney Disease

Diabetes and Hypertension

End-Stage Renal Disease

Gout

Hyperkalemia

IgAN

Kidney Transplantation

Metabolic Acidosis

Nephrology Times

Mesothelioma

Non-Small Cell Lung Cancer

Small Cell Lung Cancer

Squamous Cell Lung Carcinoma

Lung Cancers Today

Atherosclerotic Disease

Atrial Fibrillation

Heart Failure

Hypertension

Interventional Cardiology

Lipid Management

Practice Tips With Dr. Lichaa

Preventive Cardiology

Stroke

Cardiology

Breast Cancer

Gynecologic Cancer

Head and Neck Cancer

Skin Cancer

Oncology

Sleep

Urology

Diabetes

Ophthalmology

— Demodex Blepharitis

Neurology

Rheumatology

Gastroenterology

Pulmonology

Infectious Diseases

— HIV

Health and Wellness

Lupus

Future of Medicine

Orthopedics

Pharmacology

Career News

More

Conferences

CardioNerds

The Sleep Source With Dr. Morse

The Oncology Brothers

Rheumatology Rounds With Dr. Maheswaranathan

Healthcare Unfiltered

The Fellow on Call

Partners

Hurricanes & Health Care

Career Center

Expert Interviews

Subscribe